- Home
- TPR vs ASND Comparison
TPR vs ASND Comparison
Compare TPR & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPR
- ASND
- Stock Information
- Founded
- TPR 1941
- ASND 2006
- Country
- TPR United States
- ASND Denmark
- Employees
- TPR N/A
- ASND N/A
- Industry
- TPR Apparel
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- TPR Consumer Discretionary
- ASND Health Care
- Exchange
- TPR Nasdaq
- ASND Nasdaq
- Market Cap
- TPR 17.5B
- ASND 10.6B
- IPO Year
- TPR 2000
- ASND 2015
- Fundamental
- Price
- TPR $90.84
- ASND $174.18
- Analyst Decision
- TPR Buy
- ASND Strong Buy
- Analyst Count
- TPR 18
- ASND 17
- Target Price
- TPR $84.72
- ASND $220.06
- AVG Volume (30 Days)
- TPR 3.5M
- ASND 399.8K
- Earning Date
- TPR 08-14-2025
- ASND 09-02-2025
- Dividend Yield
- TPR 1.55%
- ASND N/A
- EPS Growth
- TPR 0.55
- ASND N/A
- EPS
- TPR 3.79
- ASND N/A
- Revenue
- TPR $6,878,600,000.00
- ASND $398,509,511.00
- Revenue This Year
- TPR $5.39
- ASND $75.05
- Revenue Next Year
- TPR $2.15
- ASND $78.14
- P/E Ratio
- TPR $23.80
- ASND N/A
- Revenue Growth
- TPR 2.67
- ASND 12.06
- 52 Week Low
- TPR $35.23
- ASND $111.09
- 52 Week High
- TPR $90.85
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- TPR 66.03
- ASND 51.75
- Support Level
- TPR $84.39
- ASND $167.52
- Resistance Level
- TPR $89.18
- ASND $174.34
- Average True Range (ATR)
- TPR 2.31
- ASND 5.45
- MACD
- TPR 0.17
- ASND -0.75
- Stochastic Oscillator
- TPR 94.43
- ASND 37.23
About TPR Tapestry Inc.
Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounts for about 80% of its sales and more than 90% of its operating profit. Coach products are sold through 900 company-owned stores, e-commerce, and third-party stores in North America, Asia, and Europe. Tapestry also owns Kate Spade, which generated 54% of its sales from handbags in fiscal 2024. Kate Spade is known for its colorful patterns and graphics. Meanwhile, Tapestry's smallest brand, luxury footwear maker Stuart Weitzman, is set to be sold to Caleres in the summer of 2025.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.